Design and Analytical Evaluation of an Immunoassay for Long Forms of Cardiac Troponin T
The Journal of Applied Laboratory Medicine · 05.01.2026 · 11 (1) · 36-47
DOI: 10.1093/jalm/jfaf143 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 30.09.2025. Verfasst von Rami Aalto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Unit, Department of Life Technologies, University of Turku, Turku, Finland. Hauptthemen laut MEDLINE: Myocardial Infarction, Troponin T. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Finnish Foundation for Cardiovascular Research, Clinical Research Fund, Turku University Foundation.
Abstract (Originalsprache)
Background
Cardiac troponins (cTn) are used as diagnostic biomarkers of acute myocardial infarction (MI), but elevated levels of cTn can also be observed in other conditions. We report here the design and analytical evaluation of an immunoassay that targets intact and mildly fragmented forms of cardiac troponin T (referred to as long cTnT), which has been shown to better differentiate between MI and end-stage renal disease than the current Roche Elecsys® high sensitivity cTnT assay.
Methods
The long cTnT assay was evaluated for analytical characteristics. Serum and heparin plasma sample matrices were compared and the analyte stability was studied by storing endogenous long cTnT from samples of ST-segment elevation MI patients in heparin plasma or buffer at different temperatures and subjecting samples to freeze–thaw cycles. The correlation of long cTnT levels and time after MI symptom onset was also studied.
Results
The long cTnT assay achieved a limit of detection of 10.8 ng/L and a lower limit of quantitation (10% CV) of 30.8 ng/L. The response was linear from 5 to 5000 ng/L. Serum produced significantly lower results than heparin plasma. Endogenous long cTnT tolerated freeze–thaw cycles, but stability was compromised when stored at higher temperatures. The fraction of circulating long cTnT was highest during early hours of MI.
Conclusion
The long cTnT assay presented good analytical performance. Our results support using heparin plasma as the sample material and avoiding prolonged sample storing at room temperatures. Long cTnT fraction decreases in time after the onset of type 1 MI. ClinicalTrials.gov registration: NCT04465591
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biotechnology Unit, Department of Life Technologies, University of Turku, Turku, Finland.
- Clinical Chemistry, Tyks Laboratories, Turku University Hospital, Turku, Finland.
- Heart Center, Turku University Hospital and University of Turku, Turku, Finland.
- Kidney Center, Turku University Hospital and University of Turku, Turku, Finland.
ORCID-Profile: Saara Wittfooth
Förderung
- Finnish Foundation for Cardiovascular Research
- Clinical Research Fund
- Turku University Foundation
- Finnish Society of Clinical Chemistry
- Varsinais-Suomi Regional Fund of the Finnish Cultural Foundation
Zitieren
APA
Aalto, R., Lahtinen, A., Airaksinen, K. E. J., Vasankari, T., Hellman, T., Koskimäki, L., & Wittfooth, S. (2026). Design and Analytical Evaluation of an Immunoassay for Long Forms of Cardiac Troponin T. The Journal of Applied Laboratory Medicine, 11(1), 36-47. https://doi.org/10.1093/jalm/jfaf143
Vancouver
Aalto R, Lahtinen A, Airaksinen KEJ, Vasankari T, Hellman T, Koskimäki L, et al. Design and Analytical Evaluation of an Immunoassay for Long Forms of Cardiac Troponin T. The Journal of Applied Laboratory Medicine. 2026;11(1):36-47. doi:10.1093/jalm/jfaf143
BibTeX
@article{Aalto2026,
author = {Aalto, Rami and Lahtinen, Akseli and Airaksinen, K E Juhani and Vasankari, Tuija and Hellman, Tapio and Koskimäki, Laura and Wittfooth, Saara},
title = {Design and Analytical Evaluation of an Immunoassay for Long Forms of Cardiac Troponin T},
journal = {The Journal of Applied Laboratory Medicine},
year = {2026},
volume = {11},
number = {1},
pages = {36--47},
doi = {10.1093/jalm/jfaf143}
}
EUVIMED